Baba, Tomohisa
Takemura, Tamiko
Okudela, Koji
Hebisawa, Akira
Matsushita, Shoichiro
Iwasawa, Tae
Yamakawa, Hideaki
Nakagawa, Hiroaki
Ogura, Takashi
Article History
Received: 26 February 2023
Accepted: 19 July 2023
First Online: 29 July 2023
Declarations
:
: The institutional review board of Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan approved the study protocol with written or verbal informed consent waiver due to the retrospective nature of this study (No. KCRC-18–0033). Information about the research was made available to research subjects, and we ensured that they had the opportunity to refuse to allow the research to be carried out. All methods were carried out in accordance with relevant guidelines and regulations.
: Not Applicable.
: TB reports personal fees from Nippon Boehringer Ingelheim Co.,Shionogi & Co., Ltd. and AMCO.inc. outside the submitted work.HY and TI report personal fees from Nippon Boehringer Ingelheim Co. outside the submitted work.TT, KO, AH, HN and SM have nothing to disclose related this work.TO reports personal fees from Nippon Boehringer Ingelheim Co. and Shionogi & Co., Ltd. outside the submitted work.